HK1167431A1 - Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same - Google Patents

Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same

Info

Publication number
HK1167431A1
HK1167431A1 HK12108076.6A HK12108076A HK1167431A1 HK 1167431 A1 HK1167431 A1 HK 1167431A1 HK 12108076 A HK12108076 A HK 12108076A HK 1167431 A1 HK1167431 A1 HK 1167431A1
Authority
HK
Hong Kong
Prior art keywords
hepatitis
virus
prepared
nucleic acid
expression vector
Prior art date
Application number
HK12108076.6A
Other languages
English (en)
Chinese (zh)
Inventor
脇田隆字
伊達朋子
高橋仁
Original Assignee
東麗株式會社
日本國立感染症研究所
公益財團法人東京都醫學綜合研究所
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 東麗株式會社, 日本國立感染症研究所, 公益財團法人東京都醫學綜合研究所 filed Critical 東麗株式會社
Publication of HK1167431A1 publication Critical patent/HK1167431A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24221—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
HK12108076.6A 2008-12-26 2012-08-16 Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same HK1167431A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008335016 2008-12-26
PCT/JP2009/071644 WO2010074249A1 (ja) 2008-12-26 2009-12-25 Ｃ型肝炎ウイルス由来の核酸並びにそれを用いた発現ベクター、形質転換細胞及びｃ型肝炎ウイルス粒子

Publications (1)

Publication Number Publication Date
HK1167431A1 true HK1167431A1 (en) 2012-11-30

Family

ID=42287853

Family Applications (2)

Application Number Title Priority Date Filing Date
HK12108076.6A HK1167431A1 (en) 2008-12-26 2012-08-16 Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same
HK15106692.1A HK1206062A1 (en) 2008-12-26 2015-07-14 Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK15106692.1A HK1206062A1 (en) 2008-12-26 2015-07-14 Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same

Country Status (7)

Country Link
US (1) US8834893B2 (xx)
EP (2) EP2770055A1 (xx)
JP (1) JP5665546B2 (xx)
CN (2) CN104313038A (xx)
CA (1) CA2748357A1 (xx)
HK (2) HK1167431A1 (xx)
WO (1) WO2010074249A1 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103703133B (zh) * 2011-05-31 2016-03-09 日本国立感染症研究所 来自丙型肝炎病毒j6cf株基因组的突变体复制子
WO2013031956A1 (ja) * 2011-08-31 2013-03-07 国立感染症研究所長が代表する日本国 遺伝子型３aのＣ型肝炎ウイルスゲノム由来の核酸を含む核酸構築物
US20150072418A1 (en) * 2013-08-16 2015-03-12 Gilead Sciences, Inc. Hcv genotype 4d replicons
US10222025B2 (en) * 2014-01-23 2019-03-05 Philips Lighting Holding B.V. Light diffuser, LED lamp arrangement using the same, and manufacturing method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19915178A1 (de) 1999-04-03 2000-10-05 Univ Mainz Johannes Gutenberg Hepatitis C Virus Zellkultursystem
JP2006506074A (ja) * 2002-11-13 2006-02-23 ワシントン ユニヴァーシティー Ｃ型肝炎ウイルスの複製に対して高許容性である細胞系
WO2004074507A2 (en) * 2003-02-13 2004-09-02 Merck & Co. Inc. Method to confer cell culture replication activity to different hepatitis c virus isolates
DE60333042D1 (de) * 2003-05-26 2010-07-29 Bartenschlager Ralf Eine aus dem genom von hepatitis-c-virus (hcv) genotyp 2a stammende nukleinsäure enthaltendes nukleinsäurekonstrukt und zelle mit dem dahinein transferierten nukleinsäurekonstrukt
JP4573776B2 (ja) * 2003-09-19 2010-11-04 財団法人 東京都医学研究機構 新規ｈｃｖ株由来の核酸、遺伝子、及び該遺伝子を利用したレプリコン複製細胞
CN1942585B (zh) 2004-02-20 2011-05-11 财团法人东京都医学研究机构 含人丙型肝炎病毒全长基因组的核酸构建物、核酸构建物转入其中的重组全长病毒基因组复制型细胞和生产丙型肝炎病毒颗粒的方法
US7674612B2 (en) * 2005-03-04 2010-03-09 The Rockefeller University Infectious, chimeric hepatitis C virus, methods of producing the same and methods of use thereof
JP5030065B2 (ja) 2005-09-30 2012-09-19 国立感染症研究所長 感染性ｃ型肝炎ウイルス粒子高産生系
EP2151495A4 (en) * 2007-04-27 2010-06-02 Advanced Life Science Inst Inc HCV GENE
WO2008147735A1 (en) * 2007-05-21 2008-12-04 THE GOVERNMENT OF UNITED STATES OF AMERICA as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Identification of adaptive mutations that increase infectivity of hepatitis c virus jfh1 strain in cell culture

Also Published As

Publication number Publication date
EP2385116A4 (en) 2013-09-18
JP5665546B2 (ja) 2015-02-04
US8834893B2 (en) 2014-09-16
WO2010074249A1 (ja) 2010-07-01
CN104313038A (zh) 2015-01-28
HK1206062A1 (en) 2015-12-31
JPWO2010074249A1 (ja) 2012-06-21
EP2770055A1 (en) 2014-08-27
EP2385116A1 (en) 2011-11-09
CN102361977A (zh) 2012-02-22
CA2748357A1 (en) 2010-07-01
CN102361977B (zh) 2014-09-24
US20120003720A1 (en) 2012-01-05

Similar Documents

Publication Publication Date Title
IL284578A (en) Double-stranded RNA suppressors of the hepatitis B virus, preparations containing them and their uses
IL257382B (en) Nucleic acid-lipid particles, preparations containing them and their uses
IL262667A (en) Nucleosides, nucleotides and modified nucleic acids, and their uses
IL252045B (en) Isolated nucleic acid, expression vector and cell culture comprising the nucleic acid
HK1144440A1 (en) Hepatitis c virus antibodies
HK1203077A1 (en) Modified nucleoside, nucleotide, and nucleic acid compositions
EP2622064A4 (en) NUCLEOSIDES, NUCLEOTIDES AND MODIFIED NUCLEIC ACIDS AND USES THEREOF
ZA201404061B (en) Compositions and methods for treating the hepatitis c virus
IL208744A0 (en) Nucleic acid-lipid particles, compositions comprising the same and uses thereof
HK1123055A1 (en) Hepatitis c virus nucleic acid vaccine
HK1138297A1 (en) Human antibodies against hepatitis c virus (hcv) uses thereof (hcv)
IL226383B (en) Antibodies against ccl20, preparations containing them and their uses
ZA200803131B (en) Rabies virus vector systems and compositions and methods thereof
IL212040A0 (en) Hepatitis c antibodies and uses thereof
EP2631290A4 (en) VIRUS VECTOR FOR PRIME-BOOST VACCINES WITH VACCINIAVIRUS VECTORS AND SENDAIVIRUS VECTORS
EP2048232A4 (en) NON-REPLICATIVE PARAMYXOVIRIDAE VIRUS VECTOR
HK1206062A1 (en) Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same
EP2576581A4 (en) RECOMBINANT RNA VIRUSES AND USES THEREOF
NO20072398L (no) Partikkeloppsamler med vektmaling.
GB0918615D0 (en) Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
ZA201303254B (en) Small viral rna molecules and uses thereof
EP2267120A4 (en) RECOMBINANT VACCINIAVIRUS WITH GENE OF HEPATITIS C-VIRUS
EP2626426A4 (en) HEPATITIS C VIRUS-GEN
EP2004684A4 (en) THE HEPATITIS C-VIRUS NEUTRALIZING ANTIBODIES
Clementi Sonaten für das Pianoforte [von] Muzio Clementi.